Intellectus Partners, LLC Ab Cellera Biologics Inc. Transaction History

Intellectus Partners, LLC

$361 Million
Q2 2024

A detailed history of Intellectus Partners, LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Intellectus Partners, LLC holds 545,533 shares of ABCL stock, worth $1.42 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

545,533

Previous 541,783 0.69%

Holding current value

$1.42 Million

Previous $2.45 Million 34.23%

% of portfolio

0.45%

Previous 0.65%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$2.73 - $4.73 $10,237 - $17,737	3,750 Added 0.69%	545,533 $1.61 Million
Q1 2024 May 03, 2024	SELL	$4.29 - $5.97 $1.48 Million - $2.06 Million	-345,500 Reduced 38.94%	541,783 $2.45 Million
Q4 2023 Feb 05, 2024	BUY	$3.91 - $5.93 $41,641 - $63,154	10,650 Added 1.21%	887,283 $5.07 Million
Q3 2023 Oct 25, 2023	SELL	$4.6 - $7.95 $3,679 - $6,360	-800 Reduced 0.09%	876,633 $4.03 Million
Q2 2023 Jul 31, 2023	BUY	$5.66 - $7.59 $28,017 - $37,570	4,950 Added 0.57%	877,433 $5.67 Million
Q1 2023 May 04, 2023	BUY	$7.31 - $11.18 $28,509 - $43,602	3,900 Added 0.45%	872,483 $6.58 Million
Q4 2022 Feb 02, 2023	SELL	$9.48 - $14.52 $2.11 Million - $3.24 Million	-222,922 Reduced 20.42%	868,583 $8.8 Million
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $16,099 - $23,940	1,750 Added 0.16%	1,091,505 $10.8 Million
Q2 2022 Aug 12, 2022	SELL	$5.72 - $10.65 $127,121 - $236,685	-22,224 Reduced 2.0%	1,089,755 $11.6 Million
Q1 2022 May 16, 2022	SELL	$7.46 - $14.14 $599,784 - $1.14 Million	-80,400 Reduced 6.74%	1,111,979 $10.8 Million
Q4 2021 Feb 14, 2022	SELL	$12.99 - $17.73 $403,339 - $550,516	-31,050 Reduced 2.54%	1,192,379 $17.1 Million
Q3 2021 Nov 16, 2021	BUY	$14.85 - $21.34 $244,282 - $351,043	16,450 Added 1.36%	1,223,429 $24.5 Million
Q2 2021 Aug 13, 2021	BUY	$20.19 - $34.17 $24.4 Million - $41.2 Million	1,206,979 New	1,206,979 $26.6 Million

Others Institutions Holding ABCL

# of Institutions

165

Shares Held

119M

Call Options Held

239K

Put Options Held

200K

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $744M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intellectus Partners, LLC with notifications on news.

Account

Intellectus Partners, LLC Ab Cellera Biologics Inc. Transaction History